Literature DB >> 18295654

Chronic pain and opiates: a call for moderation.

R Norman Harden1.   

Abstract

UNLABELLED: The prescription of opioid analgesics for chronic, nonterminal conditions continues as one of the most controversial and contentious issues in medicine. We have witnessed a full pendulum swing from the complete nihilism of the 1960s and 1970s to the careless zealotry of the 1990s. Neither extreme is good practice, and one hopes we are witnessing the dawn of a more moderate time of a sane and balanced appraisal of risk versus benefit in using these important tools. OVERALL ARTICLE
OBJECTIVE: To present the case for thoughtful attention and moderation in prescribing opioids to treat chronic pain conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295654     DOI: 10.1016/j.apmr.2007.12.013

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  9 in total

1.  Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.

Authors:  David I Buckley; James F Calvert; Jodi A Lapidus; Cynthia D Morris
Journal:  Ann Fam Med       Date:  2010 May-Jun       Impact factor: 5.166

2.  Predictors of change in pain and physical functioning among post-menopausal women with recurrent pain conditions in the women's health initiative observational cohort.

Authors:  Jennifer Brennan Braden; Alicia Young; Mark D Sullivan; Brian Walitt; Andrea Z Lacroix; Lisa Martin
Journal:  J Pain       Date:  2012-01       Impact factor: 5.820

3.  Retracted Article: Upregulation of miR-26b alleviates morphine tolerance by inhibiting BDNF via Wnt/β-catenin pathway in rats.

Authors:  Xing Liu; Jiefeng Geng; Huilian Bu; Junqi Ma; Yanqiu Ai
Journal:  RSC Adv       Date:  2019-12-11       Impact factor: 4.036

4.  A primary care-based interdisciplinary team approach to the treatment of chronic pain utilizing a pragmatic clinical trials framework.

Authors:  Lynn L Debar; Lindsay Kindler; Francis J Keefe; Carla A Green; David H Smith; Richard A Deyo; Katharine Ames; Adrianne Feldstein
Journal:  Transl Behav Med       Date:  2012-08-30       Impact factor: 3.046

5.  Let-7 microRNAs and Opioid Tolerance.

Authors:  Ying He; Zaijie Jim Wang
Journal:  Front Genet       Date:  2012-06-21       Impact factor: 4.599

6.  A practical and ethical solution to the opioid scheduling conundrum.

Authors:  Michael E Schatman; Beth D Darnall
Journal:  J Pain Res       Date:  2013-12-06       Impact factor: 3.133

7.  miR-365 targets β-arrestin 2 to reverse morphine tolerance in rats.

Authors:  Jian Wang; Wei Xu; Tao Zhong; Zongbin Song; Yu Zou; Zhuofeng Ding; Qulian Guo; Xinzhong Dong; Wangyuan Zou
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

8.  Association of morphine-induced analgesic tolerance with changes in gene expression of GluN1 and MOR1 in rat spinal cord and midbrain.

Authors:  Shamseddin Ahmadi; Fatemeh Miraki; Jalal Rostamzadeh
Journal:  Iran J Basic Med Sci       Date:  2016-09       Impact factor: 2.699

9.  Interdisciplinary team-based care for patients with chronic pain on long-term opioid treatment in primary care (PPACT) - Protocol for a pragmatic cluster randomized trial.

Authors:  Lynn DeBar; Lindsay Benes; Allison Bonifay; Richard A Deyo; Charles R Elder; Francis J Keefe; Michael C Leo; Carmit McMullen; Meghan Mayhew; Ashli Owen-Smith; David H Smith; Connie M Trinacty; William M Vollmer
Journal:  Contemp Clin Trials       Date:  2018-03-06       Impact factor: 2.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.